drugset / Trial / NCT05905120
Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
NaSingle-groupOpen-labelTreatment
Summary
This study was a single-arm, non-randomized, open-label clinical study to assess dopamine transporter occupancy in the brain of healthy adults using 11C-CFT positron emission tomography (PET)
Timeline
- Start
- 2023-03-02
- Primary completion
- 2023-06-30
- Completion
- 2023-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toludivenlafaxine | Unknown | 160 mg | Oral |